Abiopharma

Yap Kim Choy 🟡 adjusted position in 0 shares (1 derivative) of Cyclacel Pharmaceuticals, Inc. (CYCC) at $10.20 ($1.9M) Transaction Date: Sep 04, 2025 | Filing ID: 026573

New Form 144 - Surgery Partners, Inc. Filed: 2025-09-04 AccNo: 0001969223-25-000723 Size: 7 KB

New Form 144 - Surgery Partners, Inc. Filed: 2025-09-04 AccNo: 0001969223-25-000721 Size: 4 KB

Director MCDONNELL PADRAIG 🔴 sold 2.0K shares of AGILENT TECHNOLOGIES, INC. (A) at $124.88 Transaction Date: Sep 02, 2025 | Filing ID: 021179

New Form 144 - U S PHYSICAL THERAPY INC /NV Filed: 2025-09-04 AccNo: 0001969223-25-000720 Size: 4 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form SCHEDULE 13G - STRATA Skin Sciences, Inc. Filed: 2025-09-04 AccNo: 0001641172-25-026562 Size: 6 KB

Stazzone Peter 🟢 acquired 50.0K shares (1 derivative) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) at $4.45 Transaction Date: Sep 01, 2025 | Filing ID: 026560

New Form 144 - JOHNSON & JOHNSON Filed: 2025-09-04 AccNo: 0001959173-25-005770 Size: 4 KB

STAHLBERG JAN 🟢 acquired 1.0M shares of DiaMedica Therapeutics Inc. (DMAC) at $6.00 ($6.0M) Transaction Date: Aug 13, 2025 | Filing ID: 087410

New Form SCHEDULE 13G/A - DiaMedica Therapeutics Inc. Filed: 2025-09-04 AccNo: 0001104659-25-087405 Size: 9 KB

Gilead - Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

New Form F-6 POS - Renalytix plc Filed: 2025-09-04 AccNo: 0001193805-25-001256 Size: 717 KB